Evidence mapPaperPMID 40289973Full record

ReviewCurrent pharmaceutical design2025

Anti-hypertensive Function of Plant-derived Bioactive Peptides: A Review.

Monalisa Gochhi, Priyanka Dash, Biswakanth Kar, Deepak Pradhan, Jitu Halder, Chandan Das, Vineet Kumar Rai, Saroj Kumar Rout, Goutam Ghosh, Goutam Rath

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monalisa GochhiSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Priyanka DashSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Biswakanth KarSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Deepak PradhanSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Jitu HalderSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Chandan DasSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Vineet Kumar RaiSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Saroj Kumar RoutDepartment of Pharmaceutics, LNK International Inc, Hauppauge, New York, 11788, United States.
Goutam GhoshSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Goutam RathSchool of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.

Funding

DBT Builder project BT/INF/22/SP45078/2022
6 · The paper itself

Abstract

Hypertension is considered to be a crucial factor in the development of chronic diseases like obesity, diabetes, and Cardiovascular Disease (CVD). Several conventional medications are frequently used to manage hypertension. However, they have certain adverse effects that limit their use. Therefore, alternative medications, including bioactive peptides, could be valuable in managing CVD because they are safer, less expensive, and more effective. In light of this, this article aimed to explore the potential application of plantderived peptides for their efficient role in ameliorating hypertension. In particular, the authors summarise the current understanding of the anti-hypertensive function of plant-derived bioactive peptides, focusing on the source, isolation technique, purification process, and potential CVD applications. The potential antihypertensive peptides are highlighted in particular, and their molecular mechanisms, such as ACE inhibition, renin inhibition, and CCB blockers, are highlighted in terms of in vitro, in vivo, and in silico models. Recent literature evidence revealed that plant peptides with low molecular weight show better potential for inhibiting ACE and renin. Moreover, the molecular structure, solubility, and types of amino acids play an important role in determining antihypertensive activity. This review will improve the understanding of plant-derived bioactive peptides and provide some constructive inspiration for further research and industrial application in cardiovascular disorders.

Indexed as

Antihypertensive AgentsHypertensionPeptidesAnimalsHumansAntihypertensive AgentsPeptidesACEbioactive peptideCardiovascular disordershypertensionmolecular mechanisms.renin

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.